ASTHMA SEVERITY AND INCREASED RISK OF CARDIOVASCULAR AND CEREBROVASCULAR OUTCOMES IN PATIENTS WITH MODERATE-TO-SEVERE PERSISTENT ASTHMA.

被引：0
|
作者：
Omachi, T. A.
Haselkorn, T.
Miller, D. P.
Shah, M.
Eisner, M. D.
Chen, H.
Iribarren, C.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2014年 / 113卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P45
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [41] Imbalance of endogenous prostanoids in moderate-to-severe asthma
    Takemura, Masaya
    Niimi, Akio
    Matsumoto, Hisako
    Ueda, Tetsuya
    Yamaguchi, Masafumi
    Matsuoka, Hirofumi
    Jinnai, Makiko
    Chung, Kian Fan
    Mishima, Michiaki
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 83 - 88
  • [42] Simultaneous contractions increased in patients with asthma.
    Sadaoka, K
    Adachi, T
    Kanai, T
    Suzuki, J
    Kawakami, Y
    GASTROENTEROLOGY, 1996, 110 (04) : A749 - A749
  • [43] Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry
    Graff, Sophie
    Vanwynsberghe, Sybren
    Brusselle, Guy
    Hanon, Shane
    Sohy, Carine
    Dupont, Lieven
    Peche, Rudi
    Michils, Alain
    Pilette, Charles
    Joos, Guy
    Louis, Renaud
    Schleich, Florence
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [44] Utility of impulse oscillometry in patients with moderate to severe persistent asthma
    Jabbal, Sunny
    Manoharan, Arvind
    Lipworth, Joseph
    Lipworth, Brian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (02) : 601 - 603
  • [45] Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma
    Grossman, H. L.
    Schlender, Amory
    Alperin, Peter
    Stanley, Elizabeth L.
    Zhang, Jie
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (12) : 2779 - 2793
  • [46] DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY
    Corren, J.
    Castro, M.
    Maspero, J.
    Cosio, B.
    Kuna, P.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Nikhil, A.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S42 - S43
  • [47] Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma
    Bateman, E. D.
    Linnhof, A. E.
    Homik, L.
    Freudensprung, U.
    Smau, L.
    Engelstaetter, R.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (02) : 264 - 275
  • [48] RELATIONSHIP BETWEEN STUDY WITHDRAWAL AND BASELINE CHARACTERISTICS IN ADOLESCENTS AND ADULTS WITH MODERATE TO SEVERE PERSISTENT ASTHMA.
    Rosenwasser, L. J.
    Spector, S. L.
    Uryniak, T.
    Aggarwal, A.
    Martin, U. J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A36 - A36
  • [49] FUNCTIONAL RESPIRATORY IMAGING IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA: THE VESTIGE TRIAL
    Cox, J.
    Fogarty, C.
    Papi, A.
    Dimov, D.
    Ardeleanu, M.
    Mignot, B.
    De Backer, J.
    DePrado-Gomez, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S35 - S35
  • [50] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization
    Corren, Jonathan
    Hanania, Nicola A.
    Busse, William W.
    Sher, Lawrence D.
    Altincatal, Arman
    Hardin, Megan
    Mannent, Leda P.
    Amin, Nikhil
    Lederer, David J.
    Soler, Xavier
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (10): : 1020 - 1030
12345